MétaCan
Menu
Back to cohort
Record W4412100973 · doi:10.1093/eurjpc/zwaf392

Family history of premature atherosclerotic cardiovascular disease and lipoprotein(a) levels: a multicohort analysis

2025· article· en· W4412100973 on OpenAlexaboutno aff
Alexander C. Razavi, Harpreet Bhatia, Zeina Dardari, Anurag Mehta, Khurram Nasir, Ron Blankstein, Ijeoma Isiadinso, Arshed A. Quyyumi, Viola Vaccarino, Jonathan Fialkow, Muin J. Khoury, Fátima Coronado, Matthew J. Budoff, Roger S. Blumenthal, Seamus P. Whelton, Martin Bødtker Mortensen, Laurence Sperling, Kunihiro Matsushita, Michael J. Blaha, Omar Dzaye

Bibliographic record

VenueEuropean Journal of Preventive Cardiology · 2025
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesNational Heart, Lung, and Blood InstituteNational Institutes of HealthBaylor College of Medicine
KeywordsMedicineAtherosclerotic cardiovascular diseaseCohortFamily historyInternal medicineCohort studyDiseaseLipoprotein(a)CardiologyLipoproteinCholesterol

Abstract

fetched live from OpenAlex

Lipoprotein(a) [Lp(a)] is a risk factor for premature atherosclerotic cardiovascular disease (ASCVD), thrombosis, and aortic stenosis.1 Inherited LPA gene variants explain approximately 75–95% of the variability in plasma Lp(a),1 and genetic risk scores for LPA and measured plasma Lp(a) have very similar magnitude associations with incident ASCVD (∼25–30% risk per 55 mg/dL increase).2 Whether reported family history of premature ASCVD may assist with case finding and prioritizing those who may most benefit from Lp(a) testing is not well defined. In 2024, a United States National Lipid Association Scientific Statement recommended universal screening for Lp(a),3 joining prior European,4 Canadian,5 and Australian6 guidelines that recommend Lp(a) testing at least once in an individual’s lifetime. While clinical consensus may be shifting towards universal screening, prioritizing Lp(a) testing earlier in life in those at the highest risk may be helpful in the setting of limited healthcare system resources and office visit time. The presence of a family history of premature ASCVD independently associates with up to a two-fold higher risk of ASCVD events.7 However, this risk varies depending on the first degree relative affected, which may have implications for Lp(a) testing in routine ASCVD risk stratification. For example, a family history of premature coronary heart disease (CHD) in a sibling compared to parent more strongly associates with the presence and burden of coronary artery calcium (CAC).8 Given that Lp(a) is a risk factor for CAC9 and is more strongly associated with CHD compared to stroke, assessing the strength of association across various family history components with plasma Lp(a) levels may provide further precision for recommendations regarding Lp(a) testing in the general population. Here, we aimed to evaluate the association between family history of premature ASCVD (CHD, stroke) and plasma Lp(a) levels in the Multi-Ethnic Study of Atherosclerosis (MESA) and Atherosclerosis Risk in Communities (ARIC) Study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.004
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.002
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.251
Teacher spread0.227 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of Preventive CardiologySame topicLipoproteins and Cardiovascular HealthFrench-language works237,207